Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scanfil’s second profit warning of the year was as expected

SCANFLAnalyst Comment12.12.2024 klo 08.53
Antti ViljakainenHead of Research
Discuss

Translation: Original published in Finnish on 12/12/2024 at 08:00 am EET

Our forecasts are within the new guidance range, so we make no changes to Scanfl’s forecasts or outlook for the time being. Scanfil’s profit warning was not a surprise from the market viewpoint either, although consensus was a smidge above our estimates. We believe that the uncertainty related to Scanfil’s short-term demand outlook remains high, even if Q4 is by far the best quarter of the year for the company.  

The company downgraded its guidance ranges slightly

Scanfil announced yesterday that it will downgrade its revenue and EBIT guidance for 2024. Scanfil now expects its revenue for 2024 will be 770-780 MEUR (previous 780-840 MEUR) and its adjusted EBIT will be 53-54 MEUR (previous 54-61 MEUR). According to the company, challenges related to a few customer deliveries in the availability of materials in late Q4 and the slight weakening of demand reduced revenue and EBIT. Q4 will, however, be strong for Scanfil.

Our estimates were in line with the new guidance ranges

The profit warning was not surprising at all, as the lower limits of the previous guidance required an excellent (and the upper limits even a historically good) Q4 from the company. Our forecasts compiled in connection with the Q3 report expected Scanfil to generate an adjusted EBIT of 53 MEUR this year with a 778 MEUR revenue, both of which are within the new guidance ranges. Therefore, we maintain our forecasts unchanged for the time being despite the profit warning. However, the profit warning was a slight disappointment to the market, as consensus estimates for the current year were slightly higher than our expectations. The impact of the fairly expected profit warning on the stock was limited, as Scanfil’s price remained unchanged yesterday.

According to the guidance, Scanfil has generated a revenue of 202-212 MEUR and an adjusted EBIT of 14.2-15.2 MEUR in Q4. This corresponds to a decrease of 4-9% in revenue and an increase of 6-13% in adjusted EBIT from the comparison period, as well as a fairly good adjusted EBIT margin of approximately 7%. Scanfil's Q4 revenue and adjusted EBIT were supported by approximately 5 percentage points from the SRX acquisition completed in October. For Scanfil, Q4 is clearly the best quarter of this year, also in purely organic terms. In our view, the recovery of the MedTech&Life Science segment in particular, as well as new projects won last year transitioning into production, have supported revenue and profitability in Q4.

However, in light of the comments in the profit warning (incl. a slight weakening in demand at the end of Q4) and the guidance issued by the peer Kitron this week, Scanfil’s Q4 development, which is positive as such, does not necessarily reflect a sustained pick-up in demand and performance, but uncertainty, especially in terms of short-term volumes, is still elevated. Scanfil's earnings should, nevertheless, be bottoming out, as comparison figures will also ease starting from Q4. 

Login required

This content is only available for logged in users

Create account

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Read more on company page

Key Estimate Figures27.10.2024

202324e25e
Revenue901.5772.7844.0
growth-%6.8 %-14.3 %9.2 %
EBIT (adj.)61.353.058.7
EBIT-% (adj.)6.8 %6.9 %7.0 %
EPS (adj.)0.740.610.68
Dividend0.230.250.27
Dividend %2.9 %2.1 %2.3 %
P/E (adj.)10.619.117.1
EV/EBITDA7.010.69.4

Forum discussions

For Western companies selling to the Chinese market, local production is a competitive advantage that has become increasingly prominent in recent...
yesterday
by Pasi Hiedanpää
8
sttinfo.fi Scanfil laajentaa yhteistyötään Brukerin kanssa APAC-alueelle vastatakseen... Scanfil laajentaa yhteistyötään Brukerin Advanced X...
yesterday
by Cadel
12
Hanza, a peer company to Scanfil and Incap, published its Q3 results today, where revenue grew by 77% driven by acquisitions to SEK 2,487 million...
10/27/2026, 8:58 AM
by Tuukka Lundell
10
Antti and Tuukka have published a new company report on Scanfil following Q3 Scanfil’s Q3 figures published on Friday were operationally in ...
10/26/2026, 5:57 AM
by Sijoittaja-alokas
5
Here is Carnegie’s analysis on Scanfil following Q3 Scanfil’s Q3 report showed several encouraging signs for growth ahead, including: 1) organic...
10/24/2026, 1:15 PM
by Sijoittaja-alokas
5
Here are Antti’s and Tuukka’s quick comments on Scanfil’s Q3 results Scanfil released its Q3 report this morning. Driven by acquisitions, the...
10/23/2026, 6:26 AM
by Sijoittaja-alokas
8
And here are Scanfil’s Q3 key figures: July–September Revenue was EUR 252.2 million (191.3), an increase of 31.8% Revenue grew organically by...
10/23/2026, 5:03 AM
by Jukka
13